# Exagen Inc.: filings

XGN · Nasdaq · CIK 1274737 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xgn.md) · [Financials](/companies/xgn/financials.md) · [Filings](/companies/xgn/filings.md) · [Insiders](/companies/xgn/insiders.md)

## Reports and events: 122 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 135, 8-K 73, SC 13G/A 28, 3 25, D 24, 10-Q 21, DEFA14A 8, S-1/A 8, SC 13G 8, SCHEDULE 13G/A 8, 10-K 7, 424B5 7, DEF 14A 7, S-8 7, CORRESP 6, ARS 4, EFFECT 4, UPLOAD 4, 4/A 3, S-3 3, 144 2, DRS 2, S-1 2, SCHEDULE 13G 2, 10-K/A 1, 10-Q/A 1, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DRS/A 1, DRSLTR 1, NT 10-Q 1, S-1MEF 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 13:15 ET | [10-Q](/filings/0001274737-26-000048.md) | Quarterly report, period 2026-06-30 | 0001274737-26-000048 |
| 2026-08-04 | 12:02 ET | [8-K](/filings/0001274737-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-26-000047 |
| 2026-06-09 | 20:14 ET | [8-K](/filings/0001274737-26-000033.md) | 5.07 Shareholder vote results | 0001274737-26-000033 |
| 2026-05-11 | 13:17 ET | [10-Q](/filings/0001274737-26-000029.md) | Quarterly report, period 2026-03-31 | 0001274737-26-000029 |
| 2026-05-11 | 12:03 ET | [8-K](/filings/0001274737-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-26-000027 |
| 2026-04-27 | 21:17 ET | [DEF 14A](/filings/0001274737-26-000020.md) | Proxy statement, period 2026-06-09 | 0001274737-26-000020 |
| 2026-04-23 | 20:02 ET | [8-K](/filings/0001274737-26-000015.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001274737-26-000015 |
| 2026-03-10 | 13:22 ET | [10-K](/filings/0001274737-26-000009.md) | Annual report, period 2025-12-31 | 0001274737-26-000009 |
| 2026-03-10 | 12:03 ET | [8-K](/filings/0001274737-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-26-000007 |
| 2026-01-12 | 14:03 ET | [8-K](/filings/0001274737-26-000003.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-26-000003 |
| 2025-11-04 | 14:16 ET | [10-Q](/filings/0001274737-25-000071.md) | Quarterly report, period 2025-09-30 | 0001274737-25-000071 |
| 2025-11-04 | 13:03 ET | [8-K](/filings/0001274737-25-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000069 |
| 2025-07-29 | 13:22 ET | [10-Q](/filings/0001274737-25-000063.md) | Quarterly report, period 2025-06-30 | 0001274737-25-000063 |
| 2025-07-29 | 12:02 ET | [8-K](/filings/0001274737-25-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000061 |
| 2025-07-17 | 20:33 ET | [8-K](/filings/0001274737-25-000055.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-25-000055 |
| 2025-06-11 | 20:49 ET | [8-K](/filings/0001274737-25-000036.md) | 5.07 Shareholder vote results | 0001274737-25-000036 |
| 2025-05-09 | 20:05 ET | [8-K](/filings/0001193125-25-116881.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-116881 |
| 2025-05-08 | 20:06 ET | [8-K](/filings/0001193125-25-115946.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-115946 |
| 2025-05-05 | 13:31 ET | [10-Q](/filings/0001274737-25-000026.md) | Quarterly report, period 2025-03-31 | 0001274737-25-000026 |
| 2025-05-05 | 12:01 ET | [8-K](/filings/0001274737-25-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000023 |
| 2025-04-30 | 10:15 ET | [DEF 14A](/filings/0001193125-25-105576.md) | Proxy statement, period 2025-06-10 | 0001193125-25-105576 |
| 2025-04-28 | 20:05 ET | [8-K](/filings/0001193125-25-100447.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-100447 |
| 2025-03-11 | 13:21 ET | [10-K](/filings/0001274737-25-000019.md) | Annual report, period 2024-12-31 | 0001274737-25-000019 |
| 2025-03-11 | 12:00 ET | [8-K](/filings/0001274737-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000018 |
| 2025-01-13 | 13:00 ET | [8-K](/filings/0001274737-25-000003.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-25-000003 |
| 2024-11-12 | 14:15 ET | [10-Q](/filings/0001274737-24-000092.md) | Quarterly report, period 2024-09-30 | 0001274737-24-000092 |
| 2024-11-12 | 13:00 ET | [8-K](/filings/0001274737-24-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000091 |
| 2024-08-05 | 13:15 ET | [10-Q](/filings/0001274737-24-000079.md) | Quarterly report, period 2024-06-30 | 0001274737-24-000079 |
| 2024-08-05 | 12:00 ET | [8-K](/filings/0001274737-24-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000078 |
| 2024-08-02 | 21:20 ET | [8-K/A](/filings/0001274737-24-000074.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-24-000074 |
| 2024-08-02 | 12:15 ET | [8-K](/filings/0001274737-24-000071.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-24-000071 |
| 2024-06-11 | 20:08 ET | [8-K](/filings/0001274737-24-000056.md) | 5.07 Shareholder vote results | 0001274737-24-000056 |
| 2024-05-13 | 13:27 ET | [10-Q](/filings/0001274737-24-000048.md) | Quarterly report, period 2024-03-31 | 0001274737-24-000048 |
| 2024-05-13 | 12:00 ET | [8-K](/filings/0001274737-24-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000045 |
| 2024-04-26 | 12:32 ET | [8-K](/filings/0001274737-24-000030.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-24-000030 |
| 2024-04-26 | 12:31 ET | [DEF 14A](/filings/0001274737-24-000028.md) | Proxy statement, period 2023-12-31 | 0001274737-24-000028 |
| 2024-03-18 | 13:26 ET | [10-K](/filings/0001274737-24-000022.md) | Annual report, period 2023-12-31 | 0001274737-24-000022 |
| 2024-03-18 | 12:00 ET | [8-K](/filings/0001274737-24-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000019 |
| 2024-01-08 | 13:00 ET | [8-K](/filings/0001274737-24-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000006 |
| 2023-12-11 | 21:05 ET | [8-K](/filings/0001274737-23-000116.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001274737-23-000116 |
| 2023-11-17 | 21:30 ET | [8-K](/filings/0001274737-23-000105.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001274737-23-000105 |
| 2023-11-13 | 22:24 ET | [10-Q](/filings/0001274737-23-000103.md) | Quarterly report, period 2023-09-30 | 0001274737-23-000103 |
| 2023-11-13 | 21:05 ET | [8-K](/filings/0001274737-23-000101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-23-000101 |
| 2023-10-26 | 20:05 ET | [8-K](/filings/0001274737-23-000096.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001274737-23-000096 |
| 2023-08-07 | 13:23 ET | [10-Q](/filings/0001274737-23-000088.md) | Quarterly report, period 2023-06-30 | 0001274737-23-000088 |
| 2023-08-07 | 12:00 ET | [8-K](/filings/0001274737-23-000085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-23-000085 |
| 2023-07-24 | 20:05 ET | [8-K](/filings/0001274737-23-000074.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-23-000074 |
| 2023-06-14 | 20:50 ET | [8-K](/filings/0001274737-23-000067.md) | 5.07 Shareholder vote results | 0001274737-23-000067 |
| 2023-05-15 | 21:16 ET | [10-Q](/filings/0001274737-23-000049.md) | Quarterly report, period 2023-03-31 | 0001274737-23-000049 |
| 2023-05-15 | 20:05 ET | [8-K](/filings/0001274737-23-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-23-000046 |

Page 1 of 3. [Older](/companies/xgn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.